untitled Effects of wrist splinting for carpal tunnel syndrome 181 Key words: carpal tunnel syndrome, wrist splint, nerve conduction measurement Received 20 February 2008 Accepted 31 March 2008 Upsala J Med Sci 113 (2): 181–192, 2008 Effects of Wrist Splinting for Carpal Tunnel Syndrome and Motor Nerve Conduction Measurements Shingo Nobuta1, Katsumi Sato1, Tomowaki Nakagawa2, Masahito Hatori3, Eiji Itoi3 1 Department of Orthopaedic Surgery, Tohoku Rosai Hospital, 2 Department of Ortho- paedic Surgery, Iwate Prefectural Iwai Hospital, 3 Department of Orthopaedic Surgery, Tohoku University, School of Medicine Abstract Background: Carpal tunnel syndrome (CTS) is one of the most common disease among the entrapment neuropathies. Wrist splinting has been conventionally used for the CTS treatment. The purposes of this study were to assess the efficacy of wrist splinting for CTS, and to evaluate the value of the motor nerve conduction measure- ment as a prognostic indicator for CTS. Methods: Two hundred and fourteen hands with CTS were treated by wrist splinting, and reviewed after a mean follow up of seven months. Severity of symptoms were minimal lesions in 177 hands, intermediate lesions in 33 hands, and severe lesions in four hands. Motor nerve conduction measurement was performed in all cases before and after treatment, and distal latency (DL) and amplitude on compound muscle action potential (CMAP) from the abductor pollicis brevis (APB) muscle were analyzed. Results: According to Kelly’s grading of outcome, results were excellent in 41 hands, good in 110 hands, fair in 45 hands, and poor in 18 hands. Excellent or good results were obtained in 131 hands (74 percent) with minimal lesions, 20 hands (61 percent) with intermediate lesions, and in no cases with severe lesions. The ratio of excellent or good results was 79 percent in patients in whom DL of pre-treatment APB-CMAP was less than 8 milliseconds (ms), and 62 percent in patients whose DL was 8 ms or more, which showed a significant difference. In nine hands whose pre-treatment APB-CMAP was unrecordable, the results were good in one hand, fair in five, and poor in three. Conclusions: Wrist splinting is most effective in cases of minimal or intermediate lesions with DL of APB-CMAP less than 8 ms. If relief of symptoms is not obtained after five months of treatment by splinting, that would be the limit of splinting. Sur- gical release is recommended for cases with severe lesions and with unrecordable APB-CMAP. Introduction Carpal tunnel syndrome (CTS) is a compression neuropathy of the median nerve at the wrist, and is one of the most common entrapment neuropathies (1, 2). Ma- jority of patients with CTS were treated conservatively before having surgery of carpal tunnel release (1–5). The conservative treatments for CTS have included wrist splinting, steroid injection in the carpal tunnel, and the use of non-steroidal anti-inflammatory agents. The purposes of this study were to assess the efficacy of 182 Shingo Nobuta et al. wrist splinting for CTS, and to investigate the value of the motor nerve conduction measurement as a prognostic indicator for CTS treated by wrist splinting. Materials and methods Between 1998 and 2007, 214 hands in 167 patients (47 bilateral) with CTS were treated by wrist splinting in our institute, and reviewed after a mean follow up of 7 months (4–24). Diagnosis of CTS was established when a patient had pain or paraesthesiae in the median nerve distribution and objective clinical findings of CTS including delayed distal motor latency as mentioned later. Twenty-four patients (30 hands) were men and 143 patients (184 hands) were women. The average age was 58 years (29–81). The duration of symptoms varied from one to 240 months, the mean being 18 months. Two hundred and six hands were idiopathic CTS, six had a preexisting Colles fracture, and two had Kienboeck disease. According to Hama- da’s classification of severity of symptoms (6), 177 hands had minimal lesions with sensory disorders (grade 1), 33 hands had intermediate ones with some thenar atro- phy (grade 2), and four hands had severe ones with marked thenar atrophy and loss of thumb opposition (grade 3). Four patients with severe lesions refused surgery of carpal tunnel release and agreed to undergo treatment by wrist splinting. The wrist splint was custom designed and molded using thermoplastic mate- rial, and was applied from the volar side with rigid fixation at a neutral position (Figure 1 A, B, C). Patients were instructed to wear the splint at night and during daytime when symptomatic. Patients were followed once per month in our institute, Figure 1. A: Wrist splint design. Custom-molded, thermoplastic material, volar side, and rigid fixation at a neutral position of the wrist (radial view). B: Volar view. C: Dorsal view. Effects of wrist splinting for carpal tunnel syndrome 183 and anti-inflammatory agents or steroid injection were not used in any patient. Motor nerve conduction measurement was performed in all hands before and after treatment. Patients were examined with the arm in an outstretched position. Palmar skin temperatures were not allowed to fall below 32°C. Nicolet Viking elec- tromyography (Nicolet Instruments, Madison, WI, USA) with a 10-mm silver disc was used. Compound muscle action potential (CMAP) from the abductor polli- cis brevis (APB) muscle was recorded with surface electrodes by supramaximal stimulation of the median nerve at the wrist. Distal latency (DL) was measured from the stimulus artifact to the onset of the potential. Amplitude was measured from the baseline to the negative peak of the potential. The criterion for the normal value of DL at our department was below 4.8 milliseconds (ms) and the normal value of minimum amplitude was 0.9 millivolts (mV) (7). CTS was diagnosed when the DL of APB-CMAP was 4.8 ms or more. If APB-CMAP was not recordable, CMAP from the second lumbrical (SL) muscle was recorded and analyzed. Normal value of DL was below 4.0 ms, and minimum amplitude was 0.3 mV in SL-CMAP (7). The post-treatment results were evaluated into four categories according to relief of symptoms by Kelly et al. (8). Excellent was complete relief of symptoms, good meant persistence of occasional minor symptoms, fair was with some constant or annoying symptoms, and poor meant symptoms unchanged or worse. We compared clinical results with pre- and post-treatment DL and amplitude of APB-CMAP. The data were analyzed statistically by the Student’s t-test and the Chi-square test. P- values of less than 0.05 were considered statistically significant. Results Clinical results were excellent in 41 hands (19.2 percent), good in 110 hands (51.4 percent), fair in 45 hands (21.0 percent), and poor in 18 hands (8.4 percent). Sat- isfactory results (excellent or good) were obtained in 131 hands (74 percent) with minimal lesions, 20 hands (61 percent) with intermediate lesions, and no cases with severe lesions (Table 1). Pre-treatment APB-CMAP was recordable in 205 hands and unrecordable in nine hands. In nine hands with unrecordable APB-CMAP, one hand was good, five hands were fair, and three hands were poor. In 205 hands with recorded APB-CMAP, mean DL on pre-treatment APB-CMAP was 6.0 ms (SD 1.3) in hands with excellent results, 7.0 ms (SD 2.1) with good, and 7.8 ms (SD 2.1) with fair or poor, which showed a significant difference between each two of the three groups (Table 2). For comparison of results, we divided 205 hands with recorded APB-CMAP into two groups: group A, with slightly delayed DL of pre-treatment APB-CMAP (< 8 ms); and group B, with largely delayed DL of pre-treatment APB-CMAP (≤ 8 ms) (Figure 2 A, B). The ratio of satisfactory re- sults (excellent or good) in group A was 78.6 percent, and that in group B was 61.5 percent, which showed a significant difference (p<0.025, Table 3). Mean amplitude on pre-treatment APB-CMAP was 4.7 mV (SD 3.0) in hands with excellent results, 3.7 mV (SD 2.5) with good, and 3.1 mV (SD 2.5) with fair or poor, which showed 184 Shingo Nobuta et al. a significant difference both between the excellent and good groups, and between the excellent and fair or poor groups (Table 2). Mean DL on post-treatment APB- CMAP was 5.2 ms (SD 1.1) in the excellent group, 6.2 ms (SD 1.8) in good, and 8.0 ms (SD 2.1) in fair or poor, which showed a significant difference between each two of the three groups. Post-treatment mean DL had shortened compared with pre-treatment DL in cases with excellent and good results, but that was unchanged in cases with fair or poor results (Table 2). Mean amplitude on post-treatment APB- CMAP was 5.7 mV (SD 3.3) in the excellent group, 4.5 mV (SD 2.8) in good, and 3.3 mV (SD 2.8) in fair or poor, which showed a significant difference between each two of the three groups. Post-treatment mean amplitude was larger than pre- treatment amplitude in all groups (Table 2). Surgery of open carpal tunnel release was performed in 24 hands later, and the results of wrist splinting in these cases were fair in 7 hands and poor in 17 hands. Several other factors were examined statistically to determine whether they could predict clinical results. Duration of symptoms was 11.2 ±11.7 months in the excellent cases, 16.7 ±29.2 months in good cases, and 25.9 ±47.3 months for the fair or poor cases. Duration of symptoms revealed wide ranges and it was difficult to compare these data. Age of the patients in the excellent, good, and fair or poor cases were 53.6 ±9.7 years, 57.9 ±11.0 years, and 59.5 ±11.3 years, respectively, which showed a significant difference both between the excellent and good groups (p<0.05), and between the excellent and fair or poor groups (p<0.01). The time of final evaluation of results in the excellent cases was 4.3 ±1.6 months, while that for the good cases was 4.7 ±1.9 months and that for the fair or poor cases was 5.2 ±2.1 months, which showed a significant difference between the excellent cases and fair or poor cases (p<0.05). The time of the start in relief of symptoms in the excellent cases was 1.5 ±0.7 months, while that for the good cases was 2.0 ±1.3 months and Figure 2. A: slightly delayed dis- tal latency (DL) of pre-treatment APB-CMAP (<8 ms) in Group A; B: largely delayed DL of pre- treatment APB-CMAP (≥8 ms) in Group B. APB, abductor pollicis brevis; CMAP, compound muscle action potential Effects of wrist splinting for carpal tunnel syndrome 185 that for the fair cases was 2.8 ±1.3 months, which showed a significant difference between each two of the three groups (p<0.05). According to the self-report by the patients, symptoms recurred in 11 hands after end- ing wrist splinting. The time of recurrence after ending was 7 to 36 months, the mean being 22 months. In these 11 recurred cases, 5 cases started wrist splinting again and had relief of symptoms, and 6 cases had surgery for open carpal tunnel release later. Discussion CTS is usually diagnosed by the characteristic symptoms of paraesthesiae in the Table 1. Clinical results of 214 hands according to the severity of symptoms Number of hands (%) Results Minimal Intermediate Severe Total Excellent 38 3 0 41 (19.2%) Good 93 17 0 110 (51.4%) Fair 35 9 1 45 (21.0%) Poor 11 4 3 18 ( 8.4%) Total 177 33 4 214 (100%) Table 2. Parameters of APB-CMAP before(pre-) and at final follow-up (post-) Pre-APB-CMAP ; DL Pre-APB-CMAP ; Amp. Post-APB-CMAP ; DL Post-APB-CMAP ; Amp. 6.0 1.3 4.7 3.0 5.2 1.1 5.7 3.3 7.0 2.1 3.7 2.5 6.2 1.8 4.5 2.8 7.8 2.1 3.1 2.5 8.0 2.1 3.3 2.8 * P<0.001 ** P<0.01 *** P<0.05 * ** *** ** ** ** * N.S. * *** * *** * P<0.001 ** P<0.05 * P<0.001 ** P<0.01 *** P<0.01 * P<0.001 ** P<0.05 *** P<0.02 Excellent (n=41) Good (n=109) Fair, Poor (n=55) P value DL, distal latency (ms) ; Amp., amplitude (mV) ; N.S., not significant 186 Shingo Nobuta et al. distribution of the median nerve, positive Tinel’s sign at the wrist, Phalen’s provo- cation test, and some thenar atrophy accompanying loss of thumb opposition. Sur- gery of open or endoscopic carpal tunnel release is usually indicated for severe lesions, whereas most patients with minimal lesions are treated initially with con- servative methods (1–6). The rationale for wrist splinting was originally based on the observation that symptoms with CTS improve with rest and worsen with activity (9, 10). Synovial inflammation of the flexor tendons can cause increased pressure in the carpal tun- nel and contribute to median nerve compression (11). Carpal tunnel pressure is elevated during repetitive hand activity, and the pathophysiology of CTS is prob- ably related to the duration as well as magnitude of the pressure increase within the carpal tunnel (12). However, Lundborg (13) described that because of decreased muscular activity or faulty position during sleep at night, venous return was re- duced and carpal tunnel pressure was increased, thus nocturnal symptoms in CTS patients were frequent. Werner et al. (14) reported that the pathophysiology of CTS involved a combination of mechanical trauma and ischemic injury to the median nerve within the carpal tunnel, but the role of tendonitis and tendinosis was not well defined. With regard to the effect of wrist splinting for CTS, previous studies showed minimizing carpal tunnel pressure by reducing synovitis through resting of the wrist. Luchetti et al. (15) reported that slightly low pressures were found when the wrist was splinted, but critical pressure levels were not prevented by splinting. About the angle of wrist immobilization, Gelberman et al. (16) showed that carpal tunnel pressure was lower when the wrist was in a neutral position than when in flexion or extension. Flexion of the wrist seems to cause the flexor tendons of the fingers to be displaced against the palmar side of the carpal tunnel, increasing the pressure on both tendons and the median nerve. Phalen (11) reported splinting the wrist in slight extension, whereas Weiss et al. (17) described that the ideal position for immobilization is closer to neutral because wrist splinting in a functional posi- tion of extension did not minimize carpal tunnel pressure. Regarding the rigidity of Table 3. A relationship between DL of pre-treatment APB-CMAP and results Groups divided by DL Group A, slightly delayed distal latency (DL) of pre-treatment APB-CMAP (<8ms); group B, largely delayed DL of pre-treatment APB-CMAP ( 8ms). The ratio of satisfactory results (excellent or good) in group A and that in group B showed a significant difference (Chi-square test, p<0.025) Group A (n=140) Group B (n=65) 110 40 30 25 78.6% (110/140) 61.5% (40/65) Excellent or Good(n=150) Fair or Poor (n=55) Results (hands) Ratio of excellent or good results Effects of wrist splinting for carpal tunnel syndrome 187 splints, Rempel et al. (12) showed that flexible wrist splints failed to control carpal tunnel pressure during activities. In our patients, custom-molded rigid thermoplas- tic splints were developed because this splint design with a neutral angle was fit to achieve a neutral wrist position, and seemed to be comfortable for wearing at night. Concerning splint wearing time, our patients were instructed to wear at night only in principle, and during daytime when symptomatic. Walker et al. (18) re- ported that efficacy of neutral wrist splints was best with full-time wear instructions compared with night-only wear after six weeks of follow-up. Kruger et al. (5) and Nagaoka (19) also instructed the use of splint at night and during the day as much as possible. However, Burke et al. (20) emphasized night-only wear of splints be- cause wearing the splints during the day seemed restrictive, making it difficult to continue wearing them. Manente et al. (21) reported excellent effects of night-only wear of an innovative hand brace with stretching the middle and ring fingers for CTS. Many patients indicated that nighttime symptoms were most troublesome, and were pleased with the relief that these splints afforded. We believe that a prac- tical method of wrist splinting is wearing the splint at night and during the day as much as possible when symptomatic. About the relationship between clinical results and other factors, Celiker et al. (22) described that patients with symptom duration more than 9 months did not respond well to treatment in splinting with an anti-inflammatory drug or steroid injection. Kruger et al. (5) revealed that optimal results would be obtained if the splint was applied within the first three months of onset. Graham et al. (23) reported that symptom duration of less than three months and absence of sensory impair- ment were predictive of a lasting response to wrist splinting and steroid injections. Kaplan et al. (4) showed that five factors of unresponsiveness to treatment by wrist splint and anti-inflammatory medication were age over 50 years, duration over 10 months, constant paraesthesiae, stenosing flexor tenosynovitis, and a Phalen’s test positive in less than 30 seconds. However, Burke et al. (20) stated that duration of symptoms did not correlate with the symptom relief provided by splinting. Weiss et al. (24) reported that patients 40 years of age or younger had a significant decrease in the rate of symptom resolutions with wrist splinting and steroid injection when compared with patients over 40 years of age. In our patients, duration of symptoms revealed a wide range of time and it was difficult to be analyzed. Age of our pa- tients correlated with the results. There was a tendency for patients over 59 years to have an unsatisfactory outcome. Concerning period of treatment, Gerritsen et al. (25) reported that the success rate based on general improvement was 54 percent after three months, and was 75 percent after 18 months of wrist splinting. Mean time of final evaluation in our patients was 4.3 months in the excellent group and 4.7 months in the good, and 5.2 months in the fair or poor. Thus, we believe that if relief of symptoms is not seen after five months of splinting, this treatment should be discontinued and other treatments should be employed. Steroid injection in the carpal tunnel is a commonly used treatment similarly to wrist splinting (1, 2, 4, 11, 22, 24). Goodman et al. (26) showed that the early 188 Shingo Nobuta et al. dramatic relief of symptoms after steroid injection was associated with a decrease in the nerve conduction delay, but this improvement was not maintained. Gelber- man et al. (1) reported that symptoms recurred in most patients by nine to fifteen months after injection. In contrast, in the present series with wrist splinting, early relief of symptoms could not be obtained and the mean time of the start in relief of symptoms was 1.5 months or more. However, it is noteworthy that recurrence of symptoms was seen in only 11 hands and most cases received long-term relief from splinting. Nerve conduction study is accepted as a standard for the diagnosis of CTS (27), and delayed conduction time by recording APB-CMAP was first reported by Simp- son (28). Concerning nerve conduction study for CTS, Kruger et al. (5) showed that in patients treated by wrist splinting, motor latency improved in the symptom relief group while it deteriorated in the non-relief group, and that improvement in motor latency was probably associated with patient perception of relief. Gelberman et al. (1) stated that poor results were seen in the cases with delayed DL of more than 6 ms and absence of sensory response. In our patients, the ratio of excellent or good results in the group with delayed DL of less than 8 ms was higher than that in the group with delayed DL of 8 ms or more, and post-treatment DL had shortened in cases with excellent and good results, while it was unchanged in cases with fair or poor results compared with pre-treatment DL (Tables 2, and 3). It has been said that segmental demyelination of motor fibers causes slowing of motor conduction (29), and that the degree of delayed DL of APB-CMAP is based on the severity of demy- elination of thenar motor fibers. Thenar motor fibers are vulnerable to compression in the carpal tunnel (30). In the treatment of wrist splinting, the delayed DL of 8 ms or more may reflect the irreversible severe demyelination of the median nerve in the carpal tunnel. However, in our patients, unsatisfactory results were obtained in 21 percent of our cases with delayed DL of less than 8 ms, and satisfactory re- sults were gained in 62 percent of cases with delayed DL of 8 ms or more. In these cases, tendonitis and tendinosis seemed to have a more important role than median nerve impairment from a viewpoint of pathophysiology. In eight of nine cases with unrecordable APB-CMAP, results were unsatisfactory. Axonal degeneration results in the loss of conductive elements, which leads to reduced amplitude of potentials (29). Thus, unrecordable APB-CMAP indicates severe axonal degeneration of th- enar motor fibers, which warrants early surgical release. Werner et al. (14) reported that motor and sensory nerve conduction studies were the best means for assessing the function of the median nerve. In nerve conduction study, the most sensitive method is the median sensory conduction measurement (31), but motor conduction study is technically easy to record because of high amplitude (7). In this study, we measured only the motor nerve conduction. We evaluated the results according to relief of symptoms by Kelly et al. (8), which is a simple and subjective method of evaluation. In recent years, a self- administered questionnaire assessing symptom severity and functional status for CTS was reported (32). This instrument is highly reproducible, internally consist- ent, valid, and responsible to clinical change (18). This questionnaire can be used Effects of wrist splinting for carpal tunnel syndrome 189 to check whether a certain therapy relieves symptoms and improves the functional status (33). You et al. (27) reported that the primary symptom severity scale cor- related more strongly with the nerve conduction measures than did the secondary symptom scale. Gerritsen et al. (34) described that final success rate of splinting for CTS was 31 percent, and prognostic indicators were a short duration of CTS complaints (one year or less) and a score of 6 or less for severity of paraesthesia at night. However, Mondelli et al. (33) showed that the degree of improvement in the symptoms and functional status after surgical release could not be predicted from the pre-surgical self-administered questionnaire. In our series using subjective as- sessment and nerve conduction, a motor nerve conduction measurement was fairly valuable as a prognostic indicator for CTS. The combination of electrophysiologic measurement and evaluation of the characteristic symptoms will provide the most accurate information for CTS (31). There are some limitations in this study. First, results were evaluated according to relief of symptoms as subjective findings only. Second, the follow-up period was variable (from 4 to 24 months). Third, this study was not controlled and was retrospective. Finally, in our patients, wrist splints were worn basically at night, but during the daytime also in some patients according to their symptoms. Conclusions Wrist splinting is effective for CTS with minimal or intermediate severity with DL of APB-CMAP less than 8 ms. If relief of symptoms is not obtained after five months application of splinting, other treatment options should be employed. Sur- gical release is recommended for cases with severe lesions, or with unrecordable APB-CMAP. Acknowledgments The authors thank Ms. Hiromi Takeda and Ms. Yumi Watabe for their assistance and participants in this study for their time. References Gelberman RH, Aronson D, Weisman MH (1980) Carpal-tunnel syndrome-results of a prospec-1. tive trial of steroid injection and splinting. J Bone Joint Surg 62-A: 1181-1184. Duncan KH, Lewis RC, Foreman KA, Nordyke M (1987) Treatment of carpal tunnel syndrome 2. by members of the American Society for Surgery of the Hand: results of a questionnaire. J Hand Surg 12-A: 384-391. Quin CE (1961) Carpal tunnel syndrome: treatment by splinting. Ann Phys Med 6: 72-75.3. Kaplan SJ, Glickel SZ, Eaton RG (1990) Predictive factors in the non-surgical treatment of carpal 4. tunnel syndrome. J Hand Surg 15-B: 106-108. 190 Shingo Nobuta et al. Kruger VL, Kraft GH, Deitz JC, Ameis A, Polissar L (1991) Carpal tunnel syndrome; objective 5. measures and splint use. Arch Phys Med Rehabil 72: 517-520. Hamada Y, Ide T, Yamaguchi T (1986) The management of carpal tunnel syndrome-results of 6. prospective trial of conservative treatment. J Jpn Soc Surg Hand 3: 167-170 (in Japanese). Nobuta S (2002) Electrodiagnosis and prognosis of carpal tunnel syndrome. Seikei-saigaigeka 7. (Orthop Surg Traumatol) 45: 1051-1057 (in Japanese). Kelly CP, Pulisetti D, Jamieson AM (1994) Early experience with endoscopic carpal tunnel 8. release. J Hand Surg 19-B: 18-21. Roaf R (1947) Compression of median nerve in carpal tunnel (letter). Lancet 1: 387.9. Heathfield KWG (1957) Acroparaesthesiae and the carpal-tunnel syndrome. Lancet 2: 663-666.10. Phalen GS (1966) The carpal tunnel syndrome. Seventeen year’s experience in diagnosis and 11. treatment of six hundred fifty-four hands. J Bone Joint Surg 48-A: 211-228. Rempel D, Manojlovic R, Levinsohn DG, Bloom T, Gordon L (1994) The effect of wearing a 12. flexible wrist splint on carpal tunnel pressure during repetitive hand activity. J Hand Surg 19-A: 106-110. Lundborg G (1988) Nerve injury and repair. Churchill Livingstone, Edinburgh, 102-148.13. Werner RA, Andary M (2002) Review; Carpal tunnel syndrome: pathophysiology and clinical 14. neurophysiology. Clin Neurophys 113: 1373-1381. Luchetti R, Schoenhuber R, Alfarano M, Deluca S, De Cicco G, Landi A (1994) Serial overnight 15. recordings of intracarpal pressure in carpal tunnel syndrome patients with and without splinting. J Hand Surg 19-B: 35-37. Gelberman RH, Hergenroeder PT, Hargens AR, Lundborg GN, Akeson WH (1981) The carpal 16. tunnel syndrome: a study of carpal canal pressures. J Bone Joint Surg 63-A: 380-383. Weiss ND, Gordon L, Bloom T, So Y, Rempel D (1995) Position of the wrist associated with 17. the lowest carpal-tunnel pressure; implications for splint design. J Bone Joint Surg 77-A: 1695- 1699. Walker WC, Metzler M, Cifu DX, Swartz Z (2000) Neutral wrist splinting in carpal tunnel syn-18. drome; a comparison of night-only versus full-time wear instructions. Arch Phys Med Rehabil 81: 424-429. Nagaoka M (2002) Conservative treatment of carpal tunnel syndrome. Seikei-saigaigeka (Orthop 19. Surg Traumatol) 45: 1073-1080 (in Japanese). Burke DT, Burke MM, Stewart GW, Cambre A (1994) Splinting for carpal tunnel syndrome; in 20. search of the optimal angle. Arch Phys Med Rehabil 75: 1241-1244. Manente G, Torrieri F, Di Blasio F, Staniscia T, Romano F, Uncini A (2001) An innovative hand 21. brace for carpal tunnel syndrome: a randomized controlled trial. Muscle Nerve 24: 1020-1025. Celiker R, Arslan S, Inanici F (2002) Corticosteroid injection vs. nonsteroidal anti-inflammatory 22. drug and splinting in carpal tunnel syndome. Am J Phys Med Rehabil 81: 182-186. Graham RG, Hudson DA, Solomons M, Singer M (2003) A prospective study to assess the out-23. come of steroid injections and wrist splinting for the treatment of carpal tunnel syndrome. Plast Reconstr Surg 113: 550-556. Weiss APC, Sachar K, Gendreau M (1994) Conservative management of carpal tunnel syndrome: 24. a reexamination of steroid injection and splinting. J Hand Surg 19-A: 410-415. Gerritsen AAM, de Vet HCW, Scholten RJPM, Bertelsmann FW, de Krom MCTFM, Bouter LM 25. (2002) Splinting vs surgery in the treatment of carpal tunnel syndrome: a randomized controlled trial. JAMA 288: 1245-1251. Goodman HV, Foster JB (1962) Effect of local corticosteroid injection on median nerve conduc-26. tion in carpal tunnel syndrome. Ann Phys Med 6: 287-294. You H, Simmons Z, Freivalds A, Kothari MJ, Naidu SH (1999) Relationship between clinical 27. symptom severity scales and nerve conduction measures in carpal tunnel syndrome. Muscle Nerve 22: 497-501. Simpson JA (1956) Electrical signs in the diagnosis of carpal tunnel and related syndromes. J 28. Neurol Neurosurg Psychiat 19: 275-280. Kimura J (1984) Principles and pitfalls of nerve conduction studies. Ann Neurol 16: 415-429.29. Arita M, Masakado Y, Kimura A, Chino N (1998) The usefulness of motor conduction studies at 30. abductor pollicis brevis and lumbricalis in the diagnosis of carpal tunnel syndrome. Jpn J Rehabil Med 35: 541-548 (in Japanese). Rempel D, Evanoff B, Amadio PC, Krom M, Franklin G, Franzblau A, Gray R, Gerr F, Hagberg 31. Effects of wrist splinting for carpal tunnel syndrome 191 M, Hales T, Katz JN, Pransky G (1998) Commentary: Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies. Am J Public Health 88: 1447-1451. Levine DW, Simmons BP, Koris MJ, Daltroy LH, Hohl GG, Fossel AH, Katz JN (1993) A self-32. administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg 75-A: 1585-1592. Mondelli M, Reale F, Sicurelli F, Padua L (2000) Relationship between the self-administered 33. Boston questionnaire and electrophysiological findings in follow-up of surgically-treated carpal tunnel syndrome. J Hand Surg 25-B: 128-134. Gerritsen AAM, de Bos IBCK, Laboyrie PM, de Vet HCW, Scholten RJPM, Bouter LW (2003) 34. Splinting for carpal tunnel syndrome: prognostic indicators of success. J Neurol Neurosurg Psy- chiat 74: 1342-1344. Corresponding author: Shingo Nobuta, Department of Orthopaedic Surgery, Tohoku Rosai Hospital 4-3-21 Dainohara, Aoba-ku, Sendai, Miyagi 981-8563 Japan E mail : nobutays@jc5.so-net.ne.jp